Merus

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.

CEO

Sven Ante Lundberg

CEOSven Ante Lundberg

Employees

260

Employees260

Headquarters

Utrecht, Utrecht

HeadquartersUtrecht, Utrecht

Founded

2003

Founded2003

Employees

260

Employees260

MRUS Key Statistics

Market cap

7.19B

Market cap7.19B

Price-Earnings ratio

-17.05

Price-Earnings ratio-17.05

Dividend yield

—

Dividend yield—

Average volume

8.31M

Average volume8.31M

High today

$95.02

High today$95.02

Low today

$94.38

Low today$94.38

Open price

$94.45

Open price$94.45

Volume

2.24M

Volume2.24M

52 Week high

$95.02

52 Week high$95.02

52 Week low

$33.19

52 Week low$33.19

Analyst ratings

88%

of 17 ratings

Buy

11.8%

Hold

88.2%

Sell

People also own

Based on the portfolios of people who own MRUS. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…